At meeting held on 25 November 2014
Aurobindo Pharma announced that the Board of Directors of the Company at its Meeting held on 25 November 2014, inter alia, has considered and approved raising of the funds of the Company through Issue of Securities upto an amount of USD 350 Million or Rupee through follow on offer, qualified institutions placement, further public offer and / or private placement or by such other method subject to approval of the shareholders.The Board has constituted a Securities Issue Committee consisting five Board Members including two Independent Directors, to do all such acts, deeds, matters and things as may be required for Issue of Securities as they may deem fit in accordance with the applicable laws.
Powered by Capital Market - Live News
